arrow
E

Edward Fox

penn state health
H指数:43
被引数:8,870

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A pathologist-AI collaboration framework for enhancing diagnostic accuracies and efficiencies

用于提高诊断准确性和效率的病理学家-AI协作框架

2024-06-193
PRE
Cross-species comparative analysis of single presynapses

单种前突触的跨物种比较分析

2023-08-243
OAAI
Prediction of neuropathologic lesions from clinical data
2023-01-215
OA
Epidemiology of bone metastases
BONE
IF3.6
2022-05-0192
PREAI
Rapid and sustained B-cell depletion with subcutaneous ofatumumab in relapsing multiple sclerosis: APLIOS, a randomized phase-2 study

皮下注射ofatumumab在复发性多发性硬化症中快速和持续的b细胞耗竭: APLIOS,一项随机2期研究

2021-10-0432
OAAI
Cataclysmically disseminating neurologic presentation in an immunosuppressed lupus patient From the National Multiple Sclerosis Society Case Conference Proceedings
2019-07-010
OAAI
Real-world durability of relapse rate reduction in patients with multiple sclerosis receiving fingolimod for up to 3 years: a retrospective US claims database analysis

接受芬戈莫德治疗长达3年的多发性硬化患者复发率降低的真实世界持久性: 一项回顾性美国索赔数据库分析

2019-03-015
PREAI
Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial

Ocrelizumab可减少原发性进行性多发性硬化症患者上肢损伤的进展: 来自III期随机ORATORIO试验的发现

2018-11-1238
OAAI